EU agency accepts Sandoz application for pegfilgrastim biosimilar

ZURICH, Feb 11 (Reuters) - The European Medicines Agency (EMA) has accepted an application to review Sandoz's biosimilar to Amgen's EU-licensed Neulasta (pegfilgrastim), a recombinant human...